Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
January 7, 2019
The article discusses a groundbreaking study revealing that FDNA’s AI technology can diagnose certain genetic conditions by analyzing photos. Using the Face2Gene platform, FDNA’s system evaluates facial features to identify phenotypic markers linked to various gene mutations. Leveraging deep learning algorithms and a vast image database, the AI quickly and accurately detects genetic conditions that traditional diagnostic methods might miss. This approach enables early intervention and personalized treatment plans, significantly improving patient outcomes. The article highlights FDNA’s role in transforming genetic diagnostics, showcasing the potential of AI to revolutionize the identification and management of genetic conditions.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…